Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
76-90 of 1479 results
Isis Pharma gets $4m milestone payment from Achaogen for Phase III plazomicin trial
By PBR Staff Writer
Isis Pharmaceuticals has received a $4m milestone payment from Achaogen as part of the start of a Phase III trial of plazomicin to treat patients with serious multi-drug resistant (MDR), gram-negative bacterial infections.
Automation > IT & Software > News
HUYA Bioscience, TIPR form JV for new medical technologies in global markets
By PBR Staff Writer
HUYA Bioscience International (HUYA) has entered into a joint venture agreement with Tianjin Institute of Pharmaceutical Research (TIPR) to develop medical technologies and therapies, originating in both China and the western world, for global markets.
Automation > IT & Software > News
NeoStem enters into license deal with Rockefeller University to expand cancer immunotherapy
NeoStem (NBS), a leader in the emerging cellular therapy industry, announced that the Company has entered into an exclusive license agreement with The Rockefeller University for patented technologies that further expand the Company's intellectual property portfolio associated with its Targeted Cancer Immunotherapy Program.
Automation > IT & Software > News
Prosonix confirms potential of MCP Technology to develop new FDC therapies for respiratory diseases
Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces that it has confirmed the potential of its Multi-component Particle (MCP) Technology for creating novel inhaled, dual and triple fixed dose combination (FDC) therapies for respiratory diseases.
Automation > IT & Software > News
Marina Biotech announces continued worldwide expansion of Delivery Technology Intellectual Property Estate
Marina Biotech, a leading nucleic acid-based drug discovery and development company focused on rare diseases, had received patent protection for its comprehensive and diverse nucleic acid delivery platform with patent grants covering the following delivery technologies: SMARTICLES in Europe; TransKingdom RNA interference (tkRNAi) in Japan; Di-terminal Amino Acid Lipids (DILA2) in Australia; and lipopeptide nucleic acid delivery in China.
Automation > IT & Software > News
Cantrell improves compounding safety with closed vial filling system from Aseptic Technologies
Cantrell Drug Company has entered into an exclusive agreement to become the first human drug compounding outsourcing facility to utilize Aseptic Technologies’ closed vial system for aseptic filling of injectable drugs.
Automation > IT & Software > News
Seattle Genetics enters into antibody-drug conjugate deal with Genmab
By PBR Staff Writer
US-based Seattle Genetics has entered into a collaboration agreement with Danish biotechnology firm Genmab to develop additional antibody-drug conjugates (ADC).
Automation > IT & Software > News
USPTO issues three additional patents to strengthen Mersana's ADC technologies
By PBR Staff Writer
The US Patent and Trademark Office (USPTO) has granted three new US patents, further strengthening Mersana Therapeutics' intellectual property (IP) position in next-generation antibody-drug conjugate (ADC) technologies that use the Fleximer polymer.
Automation > IT & Software > News
Soligenix announces issuance of US Patent for ThermoVax Technology
Soligenix, a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced that the US Patent and Trademark Office granted patent 8,808,710 entitled "Method of Preparing an Immunologically-Active Adjuvant-Bound Dried Vaccine Composition."
Automation > IT & Software > News
ACT gets US patent for dendritic cells manufacturing from renewable stem cell sources
By PBR Staff Writer
The US Patent and Trademark Office (USPTO) has issued a patent to biotechnology firm Advanced Cell Technology covering methods of manufacturing dendritic cells using a highly scalable processing involving a readily renewable stem cell source as the starting materials.
Automation > IT & Software > News
SCRA Technology Ventures reports Phase II clinical trial results
SCRA Technology Ventures’ SC Launch Portfolio Company FirstString Research has recently completed a multicenter, randomized clinical trial where a novel peptide has been found to heal chronic venous leg ulcers twice as quickly as the current standard of care. FirstString’s product, Granexin gel, which contains the peptide, ACT1, possesses anti-inflammatory and regenerative properties.
Automation > IT & Software > News
Advancement of Ascendia’s nano-emulsion technology platform with Its lead development program ASD-002
Ascendia Pharmaceuticals, a start-up specialty pharmaceutical company in the business of providing formulation technologies and product development services for poorly soluble molecules, has successfully applied its nano-emulsion technology platform to a novel injectable formulation of clopidogrel - the world’s top-selling blood thinner medicine.
Automation > IT & Software > News
PPD acquires RCT Logic’s exclusive license to patented clinical trial design technology
Pharmaceutical Product Development (PPD) has acquired RCT Logic’s exclusive license from Massachusetts General Hospital (MGH) for the portfolio of patents related to its sequential parallel comparison design (SPCD).
Automation > IT & Software > News
Rexahn secures notice of allowance from USPTO for new targeted cancer drug delivery platform
Rexahn Pharmaceuticals, a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, has received a notice of allowance from the United States Patent and Trademark Office for a new delivery technology titled, “Polymeric Systems for the Delivery of Anticancer Drugs”.
Automation > IT & Software > News
Daiichi Sankyo expands TaNeDS collaborative drug discovery program in Europe
Daiichi Sankyo Company has announced details of the application for its Take a New Challenge for Drug Discovery (TaNeDS) Global Programme 2014, a collaborative drug discovery initiative for universities and research institutes in Europe.
Automation > IT & Software > News
76-90 of 1479 results